Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Bio-availability of Artemether-Lumefantrine in Severely Malnourished Children

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age between 6 and 59 months~* Weight ≥ 5 kg~* P. falciparum monoinfection confirmed on a thick blood film~* Parasitic density between 1,000 and 200,000 asexual forms/µL of blood.~* Measured axillary temperature ≥ 37.5 ° C or history of fever during the previous 24 hours~* High probability of compliance with follow-up visits (no near-term travel plans)~* Consent of a parent or guardian who is at least 18 years of age.~* According to the group: in severely malnourished, weight-for-height z-score \<-3 SD or MUAC \<115 mm, and in non-severely malnourished, weight-for-height z-score ≥- 3 standard deviations (SD), and MUAC≥ 115 mm.~Exclusion Criteria:~* General danger signs or signs of complicated malaria as defined by the WHO (Appendix 1)~* Mixed or mono-infection with another Plasmodium species detected by microscopy~* Severe anemia (hemoglobin \<5 g / dL)~* Known underlying chronic or severe disease (e.g. cardiac, renal or hepatic disease, tuberculosis, sickle cell)~* Known HIV/AIDS infection~* Known history of hypersensitivity or contra-indication to any of the study medications: artemether, lumefantrine (first-line medications), or artesunate, amodiaquine (rescue medications)~* Presence of febrile conditions due to diseases other than malaria which could alter the outcome of the study~* History of a full treatment course with AL in the past 14 days.~* Height-for-age \<-3 Z scores~* Severe complications of malnutrition requiring hospitalization in intensive care or stabilization: Severe signs of kwashiorkor, Anorexia (failure to the appetite test), Hyperemesis, Severe acute infection, Hypothermia \<35 ˚ C (axillary) or hypoglycemia, Diarrhea with dehydration, Lethargy, coma, Clinical signs of vitamin A deficiency (xerophthalmia)

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 5 Years
- Healthy Volunteers: f

Study Arms:
- Artemether-Lumefantrine (Type: EXPERIMENTAL): All patients will receive Artemether-Lumefantrine and the endpoints will be compared between the two populations of severely malnourished and non-severely malnourished children

Based on this trial design, predict the completion outcome and termination type (if applicable).